MedPath

Acute Kidney Injury in Adult Patients Supported by VA-ECMO

Completed
Conditions
Cardiogenic Shock
Acute Kidney Injury
Interventions
Other: No intervention
Registration Number
NCT04082312
Lead Sponsor
Groupe Hospitalier Pitie-Salpetriere
Brief Summary

Post-cardiotomy cardiogenic shock (PCCS) occurs in 2-6% of patients undergoing cardiac surgery, and 1% of cardiac surgery patients will require mechanical circulatory support using Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO). Acute Kidney Injury is a frequent complication in this population and negatively impacts the survival. We aimed to determine whether the timing of ECMO implantation influence the renal prognosis of these patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
347
Inclusion Criteria
  • All patients admitted in post-operative of cardiac surgery
  • Assisted by VA-ECMO
Exclusion Criteria
  • Chronic hemodialysis
  • Death occurring within the first 48 hours of VA-ECMO implantation
  • Multiple VA-ECMO during the same hospitalization.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 3No interventionPatients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + died before D10 without KDIGO stage 3 AKI
Group 1No interventionPatients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + with KDIGO stage 3 AKI
Group 2No interventionPatients admitted in the surgical intensive care unit in post-operative of cardiac surgery between January 2013 and December 2016 + Assisted by VA-ECMO + without KDIGO stage 3 AKI and alive at D10
Primary Outcome Measures
NameTimeMethod
Occurrence of a stage 3 AKIDay 10 after ECMO implantation

Number of Participants with Stage 3 Acute Kidney Injury according to the Kidney Disease: Improving Global Outcomes (KDIGO) group

Secondary Outcome Measures
NameTimeMethod
Mortality at Day 30Day 30 after ECMO implantation

Number of Deceased Participants

Mortality at 6 months6 months after ECMO implantation

Number of Deceased Participants

Trial Locations

Locations (1)

Dr Adrien Bouglé

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath